论文部分内容阅读
喹酮心安(Carteolol)和环戊了心安(Penbutolol)是两种具有部分激动活性的、从胃肠道吸收时不发生首过效应的非选择性β肾上腺素能受体阻滞剂,最近已被美国FDA批准以每天给药一次的方法治疗各种高血压,尤其适用于肾素型高血压及伴高心排出量和心动过速的高血压病人。
Carteolol and Penbutolol are two nonselective β-adrenergic receptor blockers that are partially agonistic and do not undergo first-pass effects when absorbed from the gastrointestinal tract and have recently It has been approved by the U.S. FDA to treat various types of high blood pressure once a day, especially for renin-type hypertension and hypertensive patients with high cardiac output and tachycardia.